Clinical Trials Directory

Trials / Unknown

UnknownNCT01437956

KL-6 Protein as a Biomarker of Lung Injury in Viral Bronchiolitis

Acute Bronchiolitis in Infants: Analysis of a Biomarker of Epithelial Lung Injury - Clinical and Virological Correlation

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
University Hospital, Clermont-Ferrand · Academic / Other
Sex
All
Age
1 Day – 1 Year
Healthy volunteers
Accepted

Summary

Serum KL-6 protein has been described as a biomarker of epithelial lung injury in Respiratory Syncytial Virus bronchiolitis. The investigators can imagine that epithelial injury intensity has consequences on immediate and later respiratory prognosis. Furthermore, this prognosis seems to be different according to the respiratory causative virus. The investigators propose to study, during an epidemic season, the correlation between KL-6 levels and clinical severity, and the type of viral infection.

Detailed description

Prospective, monocentric, case-control and transversal study Primary end-point: correlation between serum KL-6 level and severity of the bronchiolitis, evaluated by a clinical scoring system established at the time of the admission in Paediatric Emergency Unit Secondary end-points: respiratory virus detected by EIA and RT-PCR, phylogenetic study of rhinovirus, length of hospitalisation, immediate morbidity and mortality, risk of asthma at the age of three years old.

Conditions

Timeline

Start date
2011-10-01
Primary completion
2016-05-01
Completion
2016-10-01
First posted
2011-09-21
Last updated
2011-09-21

Source: ClinicalTrials.gov record NCT01437956. Inclusion in this directory is not an endorsement.